Programme

Please note this is an outline programme and timings are subject to minor changes. The final programme will be available in July 2024. All timings listed are in British Summer Time (BST), (GMT + 1hour).

Day 1 – Thursday 5 September 2024

10.00 — 12.30

Teaching Course 1

Basic Science

Chair: Philip Holland (King’s Collge London)

Parallel Room

10.00 — 12.30

Teaching Course 2

Children and Adolescents

Chairs:  Amy Gelfand (UC San Francisco, USA) & Prab Prabhakar (Great Ormand Street Hospital & UCL, UK)

Parallel Room

10.00 — 12.30

Teaching Course 3

Allied Health Professionals

Chair: Fiona Greenwood (King’s College Hospital NHS Trust, UK)

  • Empowering Nurses / Allied Health Professionals
  • Transition Clinic – from an Adult and Paediatric Perspective
  • Building a Novel Clinic: New Treatments and Access for Patients
  • Leading a Team as an Allied Health Professional
  • Predictors to Responding to Treatment- How do we ensure that we provide patient-centred care now that there are more options available?

Parallel Room

12.30 — 14.30

Networking Lunch

Richmond Suite

14.00 — 17.00

Teaching Course 4

Getting to Grips with Migraine in Primary Care

Chair: Kay Kennis

  • Children With Headache: Katy Munro
  • Migraine and Women’s Health: Rebecca Walker
  • New Migraine Treatments: David Watson
  • Surviving the Ten-Minute Headache Consultation: David Kernick

Parallel Room

14.30 — 15.30

Registration

Foyer

15.30 — 15.45

Opening Session

Kensington Suite

15.45 — 16.15

Plenary 1

MacDonald Critchley Lecture

Speaker: Antoinette Maassen van den Brink (Erasmus MC, Netherlands)

Kensington Suite

16.30 — 17.30

Industry Symposium 1

Supported by Teva Pharmaceuticals Europe B.V.

Kensington Suite

17.30 — 19.30

Welcome Reception

Richmond Suite

Back to top

Day 2 – Friday 6 September 2024

08.00 — 09.00

Industry Symposia 2

Supported by AbbVie Ltd.

Kensington Suite

09.00 — 10.30

Plenary 2

IHS-MTIS Symposium

Chair: Mario Peres (São Paulo Headache Center, Brazil)

  • Personalised Care
  • Elevating the bar for Responder Definition
  • Practice Recommendations

Kensington Suite

10.30 — 11.00

Coffee Break

Richmond Suite

11.00 — 12.00

Oral Communications 1

Kensington Suite

12.00 — 13.00

Industry Symposia 3

Supported by Lundbeck Ltd.

Kensington Suite

13.00 — 14.30

Lunch

Richmond Suite

13.05 — 13.35

Product Theatre 1

Richmond Suite

13.30 — 14.30

Scientific Talk

Richmond Suite

13.35 — 14.30

Digital Poster Booths Session 1

Richmond Suite

14.30 — 15.30

Parallel Session 1

Migraine Aura: What is it?

Chair: Philip Holland (King’s College London, UK) & Richard Lipton (Albert Einstein College of Medicine, USA)

  • The Bench View
  • The Clinical View
  • An Overview

Parallel Room

14.30 — 15.30

Parallel Session 2

  • Assessing Treatment Efficacy: The Role of Randomised Clinical Trials
  • Understanding Treatment Outcomes: The Significance of Real-World Data Analysis
  • Big Data Implications for Understanding Therapy

Parallel Room

15.30 — 16.00

Coffee Break

Richmond Suite

16.00 — 17.00

Plenary 3

Migraine Trust Lecture

Chair: Shazia Afridi (Guy’s and St Thomas’ Foundation Trust, UK)

Speaker: Rami Burstein (Harvard Medical School, USA) 

Kensington Suite

17.00 — 18.00

Industry Symposia 4

Supported by Dr Reddy’s Laboratories (UK) Ltd.

Kensington Suite

Back to top

Day 3 – Saturday 7 September 2024

07.30 — 08.30

Industry Symposia 5

Kensington Suite

08.30 — 10.00

Plenary 4

Sites of Action of Migraine Medications

Chair: Lars Edvinsson (University Hospital of Lund, Sweden) and Arne May (University of Hamburg, Germany)

  • Role of Intracranial Vasculature and Infusion Model
  • Key Role of the Nodes of Ranvier in the Trigeminal System
  • Role of Hypothalamus in Migraine Initiation

Kensington Suite

10.00 — 10.30

Coffee Break

Richmond Suite

10.30 — 11.30

Parallel Session 3

Novel Targets and Treatment Challenges

Chair: Mario Peres (São Paulo Headache Center, Brazil) & Raquel Gil-Gouveia (Hospital da Luz, Portugal)

  • Vestibular Migraine
  • Greater Occipital Nerve Injections
  • Melatonin

Parallel Room

10.30 — 11.30

Parallel Session 4

Unravelling biomarkers for migraine treatment: understanding treatment success (and failure)

  • Non-Responders and Super-Responders to Anti-CGRP Treatment: What have we learned?
  • Delving Into Biomarkers of Treatment Response in Chronic Migraine
  • Imaging Biomarkers, Can They Help Unlock Insights Into Treatment Success?

Parallel Room

11.30 — 12.30

Industry Symposia 6

Supported by PFIZER Ltd.

Kensington Suite

12.30 — 13.30

Lunch

30-Minute Product Theatre 2 

Supported by Lundbeck Ltd.

Richmond Suite

13.30 — 14.30

Digital poster booths Session 2

Richmond Suite

13.30 — 14.30
Scientific Talk

Richmond Suite
14.30 — 15.00

Coffee Break

30-minute Product Theatre 3

Supported by Dr. Reddy’s Laboratories (UK) Ltd

Ricmond Suite

15.00 — 16.00

Oral Communications 2

Kensington Suite

16.00 — 17.00

Parallel Session 5

Barriers to Headache Care

Chair: Rob Music (Migraine Trust, UK) & Elena Ruiz de la Torrre (EMHA, Spain)

Parallel Room

16.00 — 17.00

Parallel Session 6

Elevated and Low Intracranial Pressure and Headache

Chairs: Koen Paemeleire (Ghent University Hospital, Belgium) & Alex Sinclair (University of Birmingham, UK)

  • Raised Pressure
  • Low Pressure

Parallel Room

Back to top

Day 4 – Sunday 8 September 2024

09.30 — 11.00

Plenary Session 5

Exploring the Relationship Between Migraine and Hormones

Chair: Gisela Terwindt (Leiden University Medical Centre, Netherlands) & Raquel Gil Gouveia (Hospital da Luz, Portugal)

  • Oral Contraceptives and Migraine: What do you need to know?
  • Perimenstrual Migraine: Treatment and prevention
  • Migraine and Pregnancy: Insights, challenges, and management strategies

Kensington Suite

11.00 — 11.30

Coffee Break

Richmond Suite

11.30 — 12.00

Plenary Session 6

Nappi Cluster Award Lecture

Kensington Suite

12.00 — 12.30

Closing remarks

Kensington Suite

Back to top